Maide Medical Industrial Equipment Co., Ltd. Announcement on the Progress of Share Repurchase

MaticHoleFiller · 2026-04-08T13:20:55+00:00

Maide Medical's progress announcement on share repurchase as of March 2026: as of March 31, a total of 1,600,082 shares have been repurchased, accounting for 0.96% of the total share capital. The repurchase amount is approximately 25.63 million yuan, in compliance with relevant regulations. The company will continue to conduct repurchases based on market conditions within the repurchase period and disclose information in a timely manner.

MaticHoleFiller

2026-04-08 13:20:55

Abstract generation in progress

Stock Code: 688310 Stock Abbreviation: M&Y Healthcare Announcement No.: 2026-014

M&Y Healthcare Industrial Equipment Co., Ltd.

Announcement on Share Repurchase Progress

The board of directors of the Company and all of its directors hereby warrant that there are no false records, misleading statements, or material omissions in the contents of this announcement, and assume legal responsibility for the truthfulness, accuracy, and completeness of the contents.

Key Matters:

■

I. Basic Information on the Share Repurchase

M&Y Healthcare Industrial Equipment Co., Ltd. (hereinafter referred to as the “Company”) convened the 8th meeting of the 5th session of the board of directors and the 2nd extraordinary general meeting of shareholders on December 11, 2025, and December 30, 2025, respectively, and considered and approved the “Proposal on Repurchasing the Company’s Shares by Means of Centralized Competitive Trading.” The Company agreed that it will repurchase, by means of centralized competitive trading, some of the issued shares of the Company’s Renminbi ordinary shares (A shares) through the use of the over-raised funds from its initial public offering or its own funds, in order to reduce the Company’s registered capital. The repurchase amount shall not be less than RMB 20M (inclusive) and not more than RMB 40M (inclusive). The repurchase price shall not exceed RMB 24 per share (inclusive). The repurchase period shall be within 12 months from the date on which the general meeting of shareholders approves this share repurchase plan. For specific details, please refer to the Company’s “Repurchase Report on Repurchasing Shares by Means of Centralized Competitive Trading” (Announcement No.: 2025-057) disclosed on the website of the Shanghai Stock Exchange (www.sse.com.cn) on December 31, 2025.

II. Progress of the Share Repurchase

Pursuant to relevant provisions such as the “Provisions on Share Repurchases by Listed Companies” and the “Guidelines for Self-Regulation by Listed Companies of the Shanghai Stock Exchange No. 7 — Share Repurchases,” among other applicable regulations, the Company hereby announces the progress of its share repurchase as follows:

In March 2026, through centralized competitive trading, the Company has cumulatively repurchased 303,030 shares, accounting for 0.1823% of the Company’s total share capital of 166,219,690 shares. The highest transaction price for the repurchased shares was RMB 16.50 per share, the lowest was RMB 16.28 per share, and the total amount paid was RMB 4,979,684.17 (excluding transaction fees such as stamp duty and trading commissions).

As of March 31, 2026, through centralized competitive trading, the Company has cumulatively repurchased 1,600,082 shares, accounting for 0.9626% of the Company’s total share capital of 166,219,690 shares. The highest transaction price for the repurchased shares was RMB 16.50 per share, the lowest was RMB 15.69 per share, and the total amount paid was RMB 25,639,888.96 (excluding transaction fees such as stamp duty and trading commissions).

The repurchase of shares in this round complies with laws and regulations as well as the Company’s share repurchase plan.

III. Other Matters

The Company will strictly comply with relevant provisions such as the “Provisions on Share Repurchases by Listed Companies” and the “Guidelines for Self-Regulation by Listed Companies of the Shanghai Stock Exchange No. 7 — Share Repurchases,” among other applicable regulations, make repurchase decisions when appropriate within the repurchase period based on market conditions, and implement such decisions. Meanwhile, it will promptly fulfill its information disclosure obligations in accordance with the progress of the share repurchase matters. Investors are kindly reminded to be mindful of investment risks.

This announcement is hereby issued.

Board of Directors of M&Y Healthcare Industrial Equipment Co., Ltd.

April 2, 2026

Massive information and precise interpretation are available on the Sina Finance app

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.